Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Oxford Molecular, Yamanouchi to codevelop ion channel modulators

April 26, 1996

RMP-7 advances to phase I/II in Europe

April 26, 1996

SIBIA, Ciba-Geigy extend drug discovery agreement

April 26, 1996

Roche licenses access to LIFESEQ database

April 26, 1996

SIBIA, Salk Institute expand agreement for NAChRs

April 26, 1996

GS-2888, permeation enhancer reported by Gilead, Glaxo Wellcome

April 19, 1996

Signal, Tanabe Seiyaku to collaborate on drug discovery

April 19, 1996

Pharmacopeia will collaborate with Daiichi for drug discovery

April 12, 1996

RMP-7 phase II trials initiated

April 12, 1996

Sequana, Aurora establish drug discovery collaboration

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...